IN2013MU01117A - - Google Patents
Info
- Publication number
- IN2013MU01117A IN2013MU01117A IN1117MU2013A IN2013MU01117A IN 2013MU01117 A IN2013MU01117 A IN 2013MU01117A IN 1117MU2013 A IN1117MU2013 A IN 1117MU2013A IN 2013MU01117 A IN2013MU01117 A IN 2013MU01117A
- Authority
- IN
- India
- Prior art keywords
- preparation
- present
- relates
- propanoate
- pyridinyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229960000288 dabigatran etexilate Drugs 0.000 abstract 2
- KSGXQBZTULBEEQ-UHFFFAOYSA-N dabigatran etexilate Chemical compound C1=CC(C(N)=NC(=O)OCCCCCC)=CC=C1NCC1=NC2=CC(C(=O)N(CCC(=O)OCC)C=3N=CC=CC=3)=CC=C2N1C KSGXQBZTULBEEQ-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- BERZAEHHIUACBR-UHFFFAOYSA-N ethyl 3-[[2-(dichloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate Chemical compound C=1C=C2N(C)C(C(Cl)Cl)=NC2=CC=1C(=O)N(CCC(=O)OCC)C1=CC=CC=N1 BERZAEHHIUACBR-UHFFFAOYSA-N 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL14736463T PL2978750T3 (pl) | 2013-03-25 | 2014-03-25 | Synteza Dabigatranu |
| PCT/IN2014/000188 WO2014167577A2 (en) | 2013-03-25 | 2014-03-25 | "synthesis of dabigatran" |
| IN1117MU2013 IN2013MU01117A (en:Method) | 2013-03-25 | 2014-03-25 | |
| US14/779,911 US9688657B2 (en) | 2013-03-25 | 2014-03-25 | Synthesis of dabigatran |
| EP14736463.2A EP2978750B1 (en) | 2013-03-25 | 2014-03-25 | "synthesis of dabigatran" |
| ES14736463T ES2791187T3 (es) | 2013-03-25 | 2014-03-25 | Síntesis de dabigatrán |
| CA2907839A CA2907839C (en) | 2013-03-25 | 2014-03-25 | Synthesis of dabigatran |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1117MU2013 IN2013MU01117A (en:Method) | 2013-03-25 | 2014-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01117A true IN2013MU01117A (en:Method) | 2015-05-01 |
Family
ID=54395366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1117MU2013 IN2013MU01117A (en:Method) | 2013-03-25 | 2014-03-25 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01117A (en:Method) |
-
2014
- 2014-03-25 IN IN1117MU2013 patent/IN2013MU01117A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502091A1 (en) | Cdc7 inhibitors | |
| IL240030A0 (en) | 2-aza-bicyclo[1.2.2]heptane-3-carboxylic acid (benzyl-cyano-methyl)-modified amides inhibitors of cathepsin c | |
| IL225900A0 (en) | A process for the preparation of nicotine that includes the enzymatic reduction of 4-(methylamino)-1-(3-pyridinyl)-1-butanone | |
| PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
| CO2017004784A2 (es) | Isómeros de ácido-1-[(3-cloro-2-fluoro-fenil)metil]-4-[[3-fluoro-6-[(5-metil-1h-pirazol-3-il)amino]-2-piridil]metil]-2-metil-piperidin-4-carboxílico como inhibidores de la cinasa aurora a | |
| IN2013MU00646A (en:Method) | ||
| IN2013CH05441A (en:Method) | ||
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| MX2020011668A (es) | Antagonistas duales de receptores de neurocinina-1 (nk-1)/neurocinina-3 (nk-3) para el tratamiento de enfermedades dependientes de hormonas sexuales. | |
| MX376029B (es) | Compuestos de isoindol. | |
| PH12016500525A1 (en) | Substituted phenylalanine derivatives | |
| WO2014167577A3 (en) | "synthesis of dabigatran" | |
| IN2015DN02616A (en:Method) | ||
| NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
| IN2014MU00675A (en:Method) | ||
| WO2014068587A3 (en) | An improved process for the synthesis of dabigatran and its intermediates | |
| NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia | |
| WO2014141294A3 (en) | An improved process for the synthesis of melphalan and the hydrochloride salt | |
| IN2013MU01111A (en:Method) | ||
| MX2015017881A (es) | Método para el tratamiento y/o prevención contra encefalopatía traumática crónica grado ii. | |
| IN2015DN02601A (en:Method) | ||
| IN2013MU01117A (en:Method) | ||
| GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
| NZ724063A (en) | Pyrazine derivatives having pharmaceutical activity | |
| MX369174B (es) | Proceso para la preparación de un compuesto. |